• No products in the cart.

  • LOGIN

Requested resource is not accessible

 

CPR 100: ICI CANCER PREVENTION PRECEPTORSHIP

A multidisciplinary course on the principles and practice of cancer prevention

Eldoret, Kenya

 

18th August 2020- 29th October 2020

Lead Faculty: Lisa Hess PhD

Cancer Prevention Research Scientist

Department of Obstetrics and Gynecology

Indiana University School of Medicine and Public Health

Indianapolis, USA

 

Course Director: Fredrick Chite Asirwa MD

Consultant Physician. Medical Oncologist & Hematologist

Office of Cancer Prevention and Surveillance

International Cancer Institute (ICI)

P.O. Box 8088, Code 30100 Eldoret, Kenya

Email: chite@intercancer.com Website: www.intercancer.com

 

This educational activity is provided by International Cancer Institute (ICI)

 

Faculty (TBC)

  1. Cancer Prevention Research Scientists
  2. Epidemiologist and Population Health consultants
  3. Nutrition and Dietetics Expert
  4. Behavioural Scientist
  5. Physician & Oncologists
  6. Infectious Disease Specialist
  7. Occupational Health Expert
  8. Public Health Expert
  9. Sleep Expert
  10. Radiation Exposure Expert
  11. Environmental Health Specialist
  12. Physical Exercise Consultant
  13. Geneticists
  14. Mental Health Specialist

www.intercancer.com

ICI Education & Training Mission Statement

The ICI Preceptorship Program Mission is to measurably contribute to cancer patients’ (and populations) safety and health outcomes and to support practice improvement by providing CME/CPD activities that enhance the ability of physicians and other health-care team members to deliver quality and optimal healthcare services.

Purpose

The purpose of ICI Preceptorship Program is to develop educational activities that clearly link the needs of the learner/participants with the planning process, format and delivery of each activity, resulting in high- quality Continuing Medical Education (CME)/Continued Professional Development (CPD) opportunities that will increase the knowledge, competence and performance of health-care providers and translate into impactful population outcomes.

Target Audience

The primary target audience for this CPR 100 Course comprises public health professionals, physicians, and other healthcare professionals, research & clinical residents/fellows, policymakers, and scientists who have an interest in cancer prevention and control.

Statement of Need

Information on Prevention and Methods of prevention of cancers are not often widely disseminated, especially in sub-Saharan Africa, resulting in populations not receiving the best or most up-to-date information on the preventative aspects of cancers. Health care providers need current information on prevention strategies that are the cornerstone of any cancer control program.

This course will present a broad-based perspective in cancer prevention and control including resources, data, methods, and theories. Participants will be exposed to classical cancer epidemiology concepts in the cancer continuum (etiology, prevention, screening, diagnosis, treatment, including palliative care, and survivorship), as well as cross-cutting concepts such as cancer surveillance, epidemiology methods, and communication that are critical to the success of any cancer prevention and control activity

LEARNING OBJECTIVES

At the end of this educational activity, participants should be able:

  1. To describe the global burden of cancer, including country and regional differences while comparing and contrasting the cancer burden in different regions in the world vs Sub-Saharan Africa
  2. To understand the importance of cancer surveillance and the role of cancer registries to determine the burden and distribution of cancer in different regions and populations.
  3. Understand the importance of multidisciplinary approaches to cancer prevention and the role of the National Cancer Control Programs/ National Cancer Institutes in Cancer Prevention. Participants should also be able to Articulate the role and contribution of different disciplines to cancer prevention and control
  4. To describe the role of key lifestyle factors in the etiology of cancer, as well as approaches to cancer prevention.
  5. To understand the role that occupational and environmental exposures play in the etiology of certain cancers, as well as preventive measures.
  6. To understand the principles of clinical cancer prevention with a special emphasis on chemoprevention and future directions in the field.
  7. To describe the cancer epidemiology and interpret current information on the descriptive epidemiology, etiology, screening, and early detection of some of the major cancers, as well as identify and adapt early detection methods for site-specific tumors.
  8. Assess the strengths and weaknesses of the three main approaches to cancer prevention (primary, secondary, and tertiary) in general, and then relative to a specific country setting
  9. Categorize advantages and disadvantages of all the current cancer screening methods
  10. Discuss approaches and methods that can be used to adapt existing U.S. guidelines and evidence-based approaches in cancer prevention and control to different countries/settings
  11. To design and present a primary prevention case study working in a multidisciplinary team. Participants will also be able to list key concepts critical to designing a basic implementation and/or dissemination science project. Finally, participants will be able to describe health communication tools in cancer prevention and control that target various stakeholders.
  12. To be able to describe a low-budget approach to improve screening among disadvantaged and/or hard-to-reach communities.

Disclosure of Conflicts of Interest

International Cancer Institute (ICI) requires instructors, planners, managers and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by ICI for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

The faculty must report any financial relationships or contractual relationships they or their spouse/life partner have with commercial interests related to the content of this continuing education activity.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Method of Participation and Request for Credit

To receive credit for this activity, participants must review the activity information including learning objectives and faculty/planner disclosures, and actively participate in the educational activity. Upon successfully completing the post-test with a score of 75% or better and the post-activity evaluation, your certificate will be made available immediately.

The Course LECTURES & DISCUSSIONS

Orientation to the course (Chite) Thursday 5th November 2020 4:30-5:00 PM EAT

  1. CPR 100: CANCER PREVENTION PRECEPTORSHIP LECTURE SCHEDULE 5th November 2020 Orientation to the course Prof. Chite Asirwa
  2. 10th November 2020 Introduction to Cancer Prevention for Course CPR 100 Dr. Lisa Hess
  3. 12th November 2020 Diet/ nutrition and cancer prevention Dr. Cynthia Thompson
  4. 17th November 2020 Physical activity and cancer prevention Dr. Jenniffer W. Bea
  5. 19th November 2020 Tobacco exposure/ smoking cessation Dr. Scott Leischow
  6. 24th November 2020 Psychosocial Health and well-being in cancer prevention Dr. Wenzel/ Dr. Jeanne Carter
  7. 26th November 2020 Cancer Genetics Risk Testing Dr. Joanne Jeter
  8. 1st December 2020 Breast Cancer Prevention Dr. Patricia- Thompson Carino
  9. 3rd December 2020 Colorectal Cancer prevention Dr. Peter Lance
  10. 8th December 2020 Cancer Prevention in hard-to-reach populations Dr. Anna Maria Lopez
  11. 10th December 2020 Secondary cancer prevention and cancer survivorship Dr. Steven Plaxe
  12. 15th December 2020 Primary prevention: Occupational & Environmental Risk Factors TBD
  13. 17th December 2020 Behavioral Science and Community Interventions TBD
  14. 12th January 2020 Human and Economic benefits of Cancer Prevention TBD
  15. 14th January 2020 Radiation Exposure and Cancer Risk TBD
  16. 19th January 2020 Cancer Prevention Clinical Trials and Future Research TBD
  17. 21st January 2020 Communication, Advocacy, and policy inn cancer prevention TBD

 

Participants should be willing to spend at least 4 hours per week (comprising of 2 online virtual classes/ week and assignments, homework, projects, etc) on this course over a period of 10 weeks. (Duration 40 hours)

All those interested in registration to this course, please send your request to education@intercancer.com

 

Acknowledgment

ICI acknowledges that this CPR 100 Course has been made possible by a training grant from Roche as part of the ICI_Roche Shining Tower Project (STP)

Course Reviews

N.A

ratings
  • 5 stars0
  • 4 stars0
  • 3 stars0
  • 2 stars0
  • 1 stars0

No Reviews found for this course.

top
© 2021 International Cancer Institute. All Rights Reserved
X